Xenetic Biosciences (XBIO) revenue and earnings history
Xenetic Biosciences reported revenue of $2.98M for fiscal 2025 (year ended Dec 31, 2025), +19.0% on the year before, and net income of −$2.68M.
Over 13 years, from fiscal 2012 to fiscal 2025, revenue grew at a compound rate of +28.6% a year.
Revenue and net income, 16 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.98M+19.0% | −$2.83M | −$2.68M | −$2.29M | — | — | $65K | — | — | $7.88M | — | 10-K |
| 2024ended Dec 31, 2024 |
The latest quarter, insider trades and fund moves: Xenetic Biosciences (XBIO) on OQRO.
Common questions
What was Xenetic Biosciences's revenue in fiscal 2025?
$2.98M for the year ended Dec 31, 2025, as reported in its 10-K filed Mar 12, 2026. That is +19.0% on fiscal 2024 ($2.5M).
How fast has Xenetic Biosciences's revenue grown?
From $113K in fiscal 2012 to $2.98M in fiscal 2025: a compound annual growth rate of +28.6% over 13 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Has Xenetic Biosciences been profitable?
It reported a net loss in 15 of the years shown (2012, 2013, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023, 2024, 2025). The highest net income was −$89K in fiscal 2012.
Where these figures come from
The SEC’s companyfacts data: every figure Xenetic Biosciences tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
